Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 4,754	$ 8,688
Prepaid expenses and other current assets	1,145	1,508
Other receivables	47	472
Total current assets	5,946	10,668
Restricted cash	4,120	5,390
Property and equipment, net	11,780	12,194
Operating lease right-of-use asset	33,395	33,911
In-process research and development	10,256	10,256
Goodwill	3,490	3,490
Other assets	813	973
Total assets	69,800	76,882
Current liabilities
Accounts payable and accrued liabilities	1,448	1,705
Accrued compensation	2,815	2,191
Current portion of operating lease liabilities	4,593	4,564
Other current liabilities	372	487
Total current liabilities	9,228	8,947
Convertible Loan, non-current	254,922	153,860
Term debt, non-current	87,976	103,061
Operating lease liabilities, net of current portion	26,183	26,533
Deferred tax liability	3,077	3,077
Total liabilities	381,386	295,478
Commitments and contingencies (Note 12)
Stockholders' deficit
Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,644,703 and 36,431,444 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively	366	364
Additional paid-in capital	304,928	282,574
Accumulated deficit	(616,880)	(501,534)
Total stockholders' deficit	(311,586)	(218,596)
Total liabilities and stockholders' deficit	$ 69,800	$ 76,882